nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP2C19—prostate cancer	0.11	0.38	CbGaD
Rabeprazole—CYP1A1—prostate cancer	0.11	0.378	CbGaD
Rabeprazole—CYP3A4—prostate cancer	0.0701	0.242	CbGaD
Rabeprazole—CYP1A1—Flutamide—prostate cancer	0.0308	0.0696	CbGbCtD
Rabeprazole—ABCG2—Cabazitaxel—prostate cancer	0.0247	0.0558	CbGbCtD
Rabeprazole—ABCG2—Estrone—prostate cancer	0.0241	0.0545	CbGbCtD
Rabeprazole—CYP1A1—Estrone—prostate cancer	0.0223	0.0503	CbGbCtD
Rabeprazole—CYP2C19—Bicalutamide—prostate cancer	0.018	0.0407	CbGbCtD
Rabeprazole—CYP2C19—Nilutamide—prostate cancer	0.018	0.0407	CbGbCtD
Rabeprazole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0166	0.0374	CbGbCtD
Rabeprazole—ABCG2—Conjugated Estrogens—prostate cancer	0.0158	0.0357	CbGbCtD
Rabeprazole—CYP2C9—Bicalutamide—prostate cancer	0.015	0.0338	CbGbCtD
Rabeprazole—CYP2C9—Nilutamide—prostate cancer	0.015	0.0338	CbGbCtD
Rabeprazole—CYP2C19—Flutamide—prostate cancer	0.0149	0.0337	CbGbCtD
Rabeprazole—ABCG2—Mitoxantrone—prostate cancer	0.0144	0.0324	CbGbCtD
Rabeprazole—ABCG2—Estradiol—prostate cancer	0.0139	0.0313	CbGbCtD
Rabeprazole—CYP1A2—Flutamide—prostate cancer	0.0138	0.0311	CbGbCtD
Rabeprazole—CYP2D6—Bicalutamide—prostate cancer	0.0137	0.0309	CbGbCtD
Rabeprazole—CYP1A1—Estradiol—prostate cancer	0.0128	0.0289	CbGbCtD
Rabeprazole—CYP2D6—Abiraterone—prostate cancer	0.0113	0.0256	CbGbCtD
Rabeprazole—CYP1A2—Estrone—prostate cancer	0.00996	0.0225	CbGbCtD
Rabeprazole—ABCG2—Etoposide—prostate cancer	0.00905	0.0205	CbGbCtD
Rabeprazole—CYP2C9—Estrone—prostate cancer	0.00897	0.0203	CbGbCtD
Rabeprazole—CYP3A4—Bicalutamide—prostate cancer	0.00871	0.0197	CbGbCtD
Rabeprazole—ABCG2—Docetaxel—prostate cancer	0.00828	0.0187	CbGbCtD
Rabeprazole—CYP3A4—Estramustine—prostate cancer	0.00809	0.0183	CbGbCtD
Rabeprazole—CYP3A4—Abiraterone—prostate cancer	0.00721	0.0163	CbGbCtD
Rabeprazole—CYP3A4—Flutamide—prostate cancer	0.00721	0.0163	CbGbCtD
Rabeprazole—CYP2C9—Capecitabine—prostate cancer	0.0068	0.0154	CbGbCtD
Rabeprazole—CYP1A2—Conjugated Estrogens—prostate cancer	0.00651	0.0147	CbGbCtD
Rabeprazole—CYP2C19—Estradiol—prostate cancer	0.0062	0.014	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—prostate cancer	0.00618	0.0139	CbGbCtD
Rabeprazole—CYP1A2—Estradiol—prostate cancer	0.00572	0.0129	CbGbCtD
Rabeprazole—CYP3A4—Cabazitaxel—prostate cancer	0.00534	0.0121	CbGbCtD
Rabeprazole—CYP2C19—Prednisone—prostate cancer	0.00533	0.012	CbGbCtD
Rabeprazole—CYP3A4—Estrone—prostate cancer	0.00522	0.0118	CbGbCtD
Rabeprazole—CYP2C9—Estradiol—prostate cancer	0.00515	0.0116	CbGbCtD
Rabeprazole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00465	0.0105	CbGbCtD
Rabeprazole—CYP1A2—Etoposide—prostate cancer	0.00373	0.00843	CbGbCtD
Rabeprazole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00341	0.00771	CbGbCtD
Rabeprazole—CYP3A4—Mitoxantrone—prostate cancer	0.0031	0.00701	CbGbCtD
Rabeprazole—CYP3A4—Estradiol—prostate cancer	0.003	0.00677	CbGbCtD
Rabeprazole—CYP3A4—Prednisone—prostate cancer	0.00258	0.00582	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—prostate cancer	0.0021	0.00474	CbGbCtD
Rabeprazole—CYP3A4—Etoposide—prostate cancer	0.00196	0.00442	CbGbCtD
Rabeprazole—CYP2C19—urine—prostate cancer	0.00185	0.123	CbGeAlD
Rabeprazole—CYP3A4—Docetaxel—prostate cancer	0.00179	0.00404	CbGbCtD
Rabeprazole—CYP1A2—urine—prostate cancer	0.00151	0.101	CbGeAlD
Rabeprazole—CYP2C9—urine—prostate cancer	0.00143	0.0957	CbGeAlD
Rabeprazole—ATP4A—epithelium—prostate cancer	0.0014	0.0932	CbGeAlD
Rabeprazole—CYP3A4—Doxorubicin—prostate cancer	0.00133	0.00301	CbGbCtD
Rabeprazole—ATP4A—renal system—prostate cancer	0.00129	0.0864	CbGeAlD
Rabeprazole—CYP3A4—urine—prostate cancer	0.00109	0.073	CbGeAlD
Rabeprazole—CYP2D6—urine—prostate cancer	0.00107	0.0718	CbGeAlD
Rabeprazole—ATP4A—testis—prostate cancer	0.000836	0.0559	CbGeAlD
Rabeprazole—ABCG2—prostate gland—prostate cancer	0.000563	0.0376	CbGeAlD
Rabeprazole—ABCG2—seminal vesicle—prostate cancer	0.000476	0.0318	CbGeAlD
Rabeprazole—Omeprazole—CYP2C18—prostate cancer	0.000435	0.127	CrCbGaD
Rabeprazole—Lansoprazole—CYP2C18—prostate cancer	0.000398	0.116	CrCbGaD
Rabeprazole—CYP1A1—epithelium—prostate cancer	0.000393	0.0262	CbGeAlD
Rabeprazole—ABCG2—urethra—prostate cancer	0.000377	0.0252	CbGeAlD
Rabeprazole—CYP1A2—renal system—prostate cancer	0.000369	0.0247	CbGeAlD
Rabeprazole—CYP1A1—renal system—prostate cancer	0.000364	0.0243	CbGeAlD
Rabeprazole—Omeprazole—CYP1B1—prostate cancer	0.00036	0.105	CrCbGaD
Rabeprazole—CYP1A1—urethra—prostate cancer	0.000358	0.0239	CbGeAlD
Rabeprazole—Esomeprazole—CYP2C19—prostate cancer	0.000331	0.0963	CrCbGaD
Rabeprazole—Lansoprazole—CYP1B1—prostate cancer	0.000329	0.0957	CrCbGaD
Rabeprazole—ABCG2—bone marrow—prostate cancer	0.00029	0.0194	CbGeAlD
Rabeprazole—CYP3A4—renal system—prostate cancer	0.000267	0.0178	CbGeAlD
Rabeprazole—CYP2D6—renal system—prostate cancer	0.000263	0.0176	CbGeAlD
Rabeprazole—ABCG2—testis—prostate cancer	0.000248	0.0166	CbGeAlD
Rabeprazole—Pantoprazole—CYP2C19—prostate cancer	0.000239	0.0696	CrCbGaD
Rabeprazole—Esomeprazole—CYP3A4—prostate cancer	0.00021	0.0612	CrCbGaD
Rabeprazole—Omeprazole—CYP2C19—prostate cancer	0.000195	0.0567	CrCbGaD
Rabeprazole—Omeprazole—CYP1A1—prostate cancer	0.000194	0.0565	CrCbGaD
Rabeprazole—ABCG2—lymph node—prostate cancer	0.00018	0.012	CbGeAlD
Rabeprazole—Lansoprazole—CYP2C19—prostate cancer	0.000178	0.0519	CrCbGaD
Rabeprazole—Lansoprazole—CYP1A1—prostate cancer	0.000178	0.0517	CrCbGaD
Rabeprazole—CYP1A1—lymph node—prostate cancer	0.000171	0.0114	CbGeAlD
Rabeprazole—CYP2D6—testis—prostate cancer	0.00017	0.0114	CbGeAlD
Rabeprazole—Pantoprazole—CYP3A4—prostate cancer	0.000152	0.0443	CrCbGaD
Rabeprazole—Omeprazole—CYP3A4—prostate cancer	0.000124	0.0361	CrCbGaD
Rabeprazole—Lansoprazole—CYP3A4—prostate cancer	0.000113	0.033	CrCbGaD
Rabeprazole—Urinary tract disorder—Epirubicin—prostate cancer	2.16e-05	0.000129	CcSEcCtD
Rabeprazole—Hyperhidrosis—Capecitabine—prostate cancer	2.16e-05	0.000129	CcSEcCtD
Rabeprazole—Oedema peripheral—Epirubicin—prostate cancer	2.16e-05	0.000128	CcSEcCtD
Rabeprazole—Hypotension—Docetaxel—prostate cancer	2.15e-05	0.000128	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—prostate cancer	2.15e-05	0.000128	CcSEcCtD
Rabeprazole—Urethral disorder—Epirubicin—prostate cancer	2.15e-05	0.000128	CcSEcCtD
Rabeprazole—Loss of consciousness—Prednisone—prostate cancer	2.14e-05	0.000128	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—prostate cancer	2.13e-05	0.000127	CcSEcCtD
Rabeprazole—Anorexia—Capecitabine—prostate cancer	2.13e-05	0.000127	CcSEcCtD
Rabeprazole—Nausea—Estradiol—prostate cancer	2.13e-05	0.000127	CcSEcCtD
Rabeprazole—Vomiting—Mitoxantrone—prostate cancer	2.12e-05	0.000126	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—prostate cancer	2.12e-05	0.000126	CcSEcCtD
Rabeprazole—Convulsion—Prednisone—prostate cancer	2.11e-05	0.000126	CcSEcCtD
Rabeprazole—Visual impairment—Epirubicin—prostate cancer	2.11e-05	0.000126	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—prostate cancer	2.11e-05	0.000125	CcSEcCtD
Rabeprazole—Hypertension—Prednisone—prostate cancer	2.1e-05	0.000125	CcSEcCtD
Rabeprazole—Rash—Mitoxantrone—prostate cancer	2.1e-05	0.000125	CcSEcCtD
Rabeprazole—Dermatitis—Mitoxantrone—prostate cancer	2.1e-05	0.000125	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.1e-05	0.000125	CcSEcCtD
Rabeprazole—Headache—Mitoxantrone—prostate cancer	2.09e-05	0.000124	CcSEcCtD
Rabeprazole—Hypotension—Capecitabine—prostate cancer	2.09e-05	0.000124	CcSEcCtD
Rabeprazole—Insomnia—Docetaxel—prostate cancer	2.09e-05	0.000124	CcSEcCtD
Rabeprazole—Myalgia—Prednisone—prostate cancer	2.07e-05	0.000124	CcSEcCtD
Rabeprazole—Arthralgia—Prednisone—prostate cancer	2.07e-05	0.000124	CcSEcCtD
Rabeprazole—Paraesthesia—Docetaxel—prostate cancer	2.07e-05	0.000123	CcSEcCtD
Rabeprazole—Erythema multiforme—Epirubicin—prostate cancer	2.07e-05	0.000123	CcSEcCtD
Rabeprazole—Anxiety—Prednisone—prostate cancer	2.07e-05	0.000123	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—prostate cancer	2.06e-05	0.000123	CcSEcCtD
Rabeprazole—Dyspnoea—Docetaxel—prostate cancer	2.06e-05	0.000122	CcSEcCtD
Rabeprazole—Somnolence—Docetaxel—prostate cancer	2.05e-05	0.000122	CcSEcCtD
Rabeprazole—Discomfort—Prednisone—prostate cancer	2.05e-05	0.000122	CcSEcCtD
Rabeprazole—Eye disorder—Epirubicin—prostate cancer	2.05e-05	0.000122	CcSEcCtD
Rabeprazole—Hypersensitivity—Etoposide—prostate cancer	2.04e-05	0.000122	CcSEcCtD
Rabeprazole—Tinnitus—Epirubicin—prostate cancer	2.04e-05	0.000122	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.03e-05	0.000121	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—prostate cancer	2.03e-05	0.000121	CcSEcCtD
Rabeprazole—Dyspepsia—Docetaxel—prostate cancer	2.03e-05	0.000121	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—prostate cancer	2.03e-05	0.000121	CcSEcCtD
Rabeprazole—Insomnia—Capecitabine—prostate cancer	2.02e-05	0.00012	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—prostate cancer	2.01e-05	0.00012	CcSEcCtD
Rabeprazole—Paraesthesia—Capecitabine—prostate cancer	2e-05	0.000119	CcSEcCtD
Rabeprazole—Decreased appetite—Docetaxel—prostate cancer	2e-05	0.000119	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—prostate cancer	2e-05	0.000119	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—prostate cancer	2e-05	0.000119	CcSEcCtD
Rabeprazole—Asthenia—Etoposide—prostate cancer	1.99e-05	0.000119	CcSEcCtD
Rabeprazole—Dyspnoea—Capecitabine—prostate cancer	1.99e-05	0.000119	CcSEcCtD
Rabeprazole—Anaphylactic shock—Prednisone—prostate cancer	1.99e-05	0.000118	CcSEcCtD
Rabeprazole—Oedema—Prednisone—prostate cancer	1.99e-05	0.000118	CcSEcCtD
Rabeprazole—Angiopathy—Epirubicin—prostate cancer	1.99e-05	0.000118	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—prostate cancer	1.99e-05	0.000118	CcSEcCtD
Rabeprazole—Nausea—Mitoxantrone—prostate cancer	1.98e-05	0.000118	CcSEcCtD
Rabeprazole—Constipation—Docetaxel—prostate cancer	1.97e-05	0.000117	CcSEcCtD
Rabeprazole—Pain—Docetaxel—prostate cancer	1.97e-05	0.000117	CcSEcCtD
Rabeprazole—Dyspepsia—Capecitabine—prostate cancer	1.97e-05	0.000117	CcSEcCtD
Rabeprazole—Chills—Epirubicin—prostate cancer	1.96e-05	0.000117	CcSEcCtD
Rabeprazole—Pruritus—Etoposide—prostate cancer	1.96e-05	0.000117	CcSEcCtD
Rabeprazole—Shock—Prednisone—prostate cancer	1.96e-05	0.000117	CcSEcCtD
Rabeprazole—Arrhythmia—Epirubicin—prostate cancer	1.96e-05	0.000116	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—prostate cancer	1.95e-05	0.000116	CcSEcCtD
Rabeprazole—Tachycardia—Prednisone—prostate cancer	1.94e-05	0.000116	CcSEcCtD
Rabeprazole—Decreased appetite—Capecitabine—prostate cancer	1.94e-05	0.000116	CcSEcCtD
Rabeprazole—Alopecia—Epirubicin—prostate cancer	1.93e-05	0.000115	CcSEcCtD
Rabeprazole—Hyperhidrosis—Prednisone—prostate cancer	1.92e-05	0.000114	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—prostate cancer	1.92e-05	0.000114	CcSEcCtD
Rabeprazole—Pain—Capecitabine—prostate cancer	1.91e-05	0.000114	CcSEcCtD
Rabeprazole—Constipation—Capecitabine—prostate cancer	1.91e-05	0.000114	CcSEcCtD
Rabeprazole—Erythema—Epirubicin—prostate cancer	1.91e-05	0.000113	CcSEcCtD
Rabeprazole—Malnutrition—Epirubicin—prostate cancer	1.91e-05	0.000113	CcSEcCtD
Rabeprazole—Feeling abnormal—Docetaxel—prostate cancer	1.9e-05	0.000113	CcSEcCtD
Rabeprazole—Diarrhoea—Etoposide—prostate cancer	1.9e-05	0.000113	CcSEcCtD
Rabeprazole—Anorexia—Prednisone—prostate cancer	1.9e-05	0.000113	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—prostate cancer	1.89e-05	0.000113	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—prostate cancer	1.89e-05	0.000112	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Docetaxel—prostate cancer	1.89e-05	0.000112	CcSEcCtD
Rabeprazole—Flatulence—Epirubicin—prostate cancer	1.88e-05	0.000112	CcSEcCtD
Rabeprazole—Tension—Epirubicin—prostate cancer	1.87e-05	0.000111	CcSEcCtD
Rabeprazole—Dysgeusia—Epirubicin—prostate cancer	1.87e-05	0.000111	CcSEcCtD
Rabeprazole—Nervousness—Epirubicin—prostate cancer	1.85e-05	0.00011	CcSEcCtD
Rabeprazole—Back pain—Epirubicin—prostate cancer	1.84e-05	0.00011	CcSEcCtD
Rabeprazole—Feeling abnormal—Capecitabine—prostate cancer	1.84e-05	0.00011	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—prostate cancer	1.84e-05	0.000109	CcSEcCtD
Rabeprazole—Dizziness—Etoposide—prostate cancer	1.83e-05	0.000109	CcSEcCtD
Rabeprazole—Muscle spasms—Epirubicin—prostate cancer	1.83e-05	0.000109	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Capecitabine—prostate cancer	1.83e-05	0.000109	CcSEcCtD
Rabeprazole—Body temperature increased—Docetaxel—prostate cancer	1.82e-05	0.000109	CcSEcCtD
Rabeprazole—Abdominal pain—Docetaxel—prostate cancer	1.82e-05	0.000109	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—prostate cancer	1.82e-05	0.000108	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Prednisone—prostate cancer	1.81e-05	0.000108	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—prostate cancer	1.81e-05	0.000108	CcSEcCtD
Rabeprazole—Insomnia—Prednisone—prostate cancer	1.8e-05	0.000107	CcSEcCtD
Rabeprazole—Vision blurred—Epirubicin—prostate cancer	1.8e-05	0.000107	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—prostate cancer	1.79e-05	0.000107	CcSEcCtD
Rabeprazole—Paraesthesia—Prednisone—prostate cancer	1.79e-05	0.000106	CcSEcCtD
Rabeprazole—Urticaria—Capecitabine—prostate cancer	1.77e-05	0.000106	CcSEcCtD
Rabeprazole—Ill-defined disorder—Epirubicin—prostate cancer	1.77e-05	0.000105	CcSEcCtD
Rabeprazole—Body temperature increased—Capecitabine—prostate cancer	1.76e-05	0.000105	CcSEcCtD
Rabeprazole—Abdominal pain—Capecitabine—prostate cancer	1.76e-05	0.000105	CcSEcCtD
Rabeprazole—Vomiting—Etoposide—prostate cancer	1.76e-05	0.000105	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—prostate cancer	1.76e-05	0.000105	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—prostate cancer	1.76e-05	0.000105	CcSEcCtD
Rabeprazole—Anaemia—Epirubicin—prostate cancer	1.76e-05	0.000105	CcSEcCtD
Rabeprazole—Agitation—Epirubicin—prostate cancer	1.75e-05	0.000104	CcSEcCtD
Rabeprazole—Dyspepsia—Prednisone—prostate cancer	1.75e-05	0.000104	CcSEcCtD
Rabeprazole—Rash—Etoposide—prostate cancer	1.75e-05	0.000104	CcSEcCtD
Rabeprazole—Dermatitis—Etoposide—prostate cancer	1.75e-05	0.000104	CcSEcCtD
Rabeprazole—Headache—Etoposide—prostate cancer	1.74e-05	0.000104	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—prostate cancer	1.74e-05	0.000103	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—prostate cancer	1.73e-05	0.000103	CcSEcCtD
Rabeprazole—Decreased appetite—Prednisone—prostate cancer	1.73e-05	0.000103	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—prostate cancer	1.73e-05	0.000103	CcSEcCtD
Rabeprazole—Malaise—Epirubicin—prostate cancer	1.72e-05	0.000102	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—prostate cancer	1.71e-05	0.000102	CcSEcCtD
Rabeprazole—Vertigo—Epirubicin—prostate cancer	1.71e-05	0.000102	CcSEcCtD
Rabeprazole—Syncope—Epirubicin—prostate cancer	1.71e-05	0.000102	CcSEcCtD
Rabeprazole—Leukopenia—Epirubicin—prostate cancer	1.71e-05	0.000102	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—prostate cancer	1.71e-05	0.000102	CcSEcCtD
Rabeprazole—Constipation—Prednisone—prostate cancer	1.7e-05	0.000101	CcSEcCtD
Rabeprazole—Hypersensitivity—Docetaxel—prostate cancer	1.7e-05	0.000101	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—prostate cancer	1.7e-05	0.000101	CcSEcCtD
Rabeprazole—Palpitations—Epirubicin—prostate cancer	1.68e-05	0.0001	CcSEcCtD
Rabeprazole—Loss of consciousness—Epirubicin—prostate cancer	1.67e-05	9.97e-05	CcSEcCtD
Rabeprazole—Cough—Epirubicin—prostate cancer	1.66e-05	9.9e-05	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—prostate cancer	1.66e-05	9.9e-05	CcSEcCtD
Rabeprazole—Asthenia—Docetaxel—prostate cancer	1.65e-05	9.85e-05	CcSEcCtD
Rabeprazole—Convulsion—Epirubicin—prostate cancer	1.65e-05	9.83e-05	CcSEcCtD
Rabeprazole—Nausea—Etoposide—prostate cancer	1.65e-05	9.81e-05	CcSEcCtD
Rabeprazole—Hypertension—Epirubicin—prostate cancer	1.65e-05	9.8e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Capecitabine—prostate cancer	1.64e-05	9.79e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Prednisone—prostate cancer	1.64e-05	9.76e-05	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—prostate cancer	1.64e-05	9.74e-05	CcSEcCtD
Rabeprazole—Pruritus—Docetaxel—prostate cancer	1.63e-05	9.71e-05	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—prostate cancer	1.63e-05	9.7e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Prednisone—prostate cancer	1.63e-05	9.68e-05	CcSEcCtD
Rabeprazole—Chest pain—Epirubicin—prostate cancer	1.62e-05	9.66e-05	CcSEcCtD
Rabeprazole—Myalgia—Epirubicin—prostate cancer	1.62e-05	9.66e-05	CcSEcCtD
Rabeprazole—Arthralgia—Epirubicin—prostate cancer	1.62e-05	9.66e-05	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—prostate cancer	1.62e-05	9.65e-05	CcSEcCtD
Rabeprazole—Anxiety—Epirubicin—prostate cancer	1.62e-05	9.63e-05	CcSEcCtD
Rabeprazole—Discomfort—Epirubicin—prostate cancer	1.6e-05	9.55e-05	CcSEcCtD
Rabeprazole—Asthenia—Capecitabine—prostate cancer	1.6e-05	9.54e-05	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—prostate cancer	1.59e-05	9.47e-05	CcSEcCtD
Rabeprazole—Dry mouth—Epirubicin—prostate cancer	1.59e-05	9.45e-05	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—prostate cancer	1.58e-05	9.43e-05	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—prostate cancer	1.58e-05	9.42e-05	CcSEcCtD
Rabeprazole—Urticaria—Prednisone—prostate cancer	1.58e-05	9.41e-05	CcSEcCtD
Rabeprazole—Pruritus—Capecitabine—prostate cancer	1.58e-05	9.41e-05	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—prostate cancer	1.58e-05	9.4e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Docetaxel—prostate cancer	1.58e-05	9.39e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Prednisone—prostate cancer	1.57e-05	9.36e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Prednisone—prostate cancer	1.57e-05	9.36e-05	CcSEcCtD
Rabeprazole—Confusional state—Epirubicin—prostate cancer	1.57e-05	9.34e-05	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—prostate cancer	1.56e-05	9.28e-05	CcSEcCtD
Rabeprazole—Anaphylactic shock—Epirubicin—prostate cancer	1.56e-05	9.26e-05	CcSEcCtD
Rabeprazole—Oedema—Epirubicin—prostate cancer	1.56e-05	9.26e-05	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—prostate cancer	1.55e-05	9.23e-05	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—prostate cancer	1.54e-05	9.16e-05	CcSEcCtD
Rabeprazole—Shock—Epirubicin—prostate cancer	1.53e-05	9.11e-05	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—prostate cancer	1.53e-05	9.1e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Capecitabine—prostate cancer	1.53e-05	9.1e-05	CcSEcCtD
Rabeprazole—Dizziness—Docetaxel—prostate cancer	1.52e-05	9.08e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Epirubicin—prostate cancer	1.52e-05	9.07e-05	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—prostate cancer	1.52e-05	9.07e-05	CcSEcCtD
Rabeprazole—Tachycardia—Epirubicin—prostate cancer	1.52e-05	9.04e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Epirubicin—prostate cancer	1.5e-05	8.95e-05	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—prostate cancer	1.5e-05	8.94e-05	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—prostate cancer	1.5e-05	8.94e-05	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—prostate cancer	1.5e-05	8.94e-05	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—prostate cancer	1.5e-05	8.91e-05	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—prostate cancer	1.48e-05	8.83e-05	CcSEcCtD
Rabeprazole—Anorexia—Epirubicin—prostate cancer	1.48e-05	8.83e-05	CcSEcCtD
Rabeprazole—Dizziness—Capecitabine—prostate cancer	1.48e-05	8.79e-05	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—prostate cancer	1.47e-05	8.74e-05	CcSEcCtD
Rabeprazole—Vomiting—Docetaxel—prostate cancer	1.47e-05	8.73e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Prednisone—prostate cancer	1.47e-05	8.72e-05	CcSEcCtD
Rabeprazole—Rash—Docetaxel—prostate cancer	1.45e-05	8.66e-05	CcSEcCtD
Rabeprazole—Hypotension—Epirubicin—prostate cancer	1.45e-05	8.65e-05	CcSEcCtD
Rabeprazole—Dermatitis—Docetaxel—prostate cancer	1.45e-05	8.65e-05	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—prostate cancer	1.45e-05	8.64e-05	CcSEcCtD
Rabeprazole—Headache—Docetaxel—prostate cancer	1.44e-05	8.6e-05	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—prostate cancer	1.44e-05	8.57e-05	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—prostate cancer	1.44e-05	8.57e-05	CcSEcCtD
Rabeprazole—Asthenia—Prednisone—prostate cancer	1.43e-05	8.5e-05	CcSEcCtD
Rabeprazole—Vomiting—Capecitabine—prostate cancer	1.42e-05	8.45e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.42e-05	8.44e-05	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—prostate cancer	1.42e-05	8.43e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—prostate cancer	1.41e-05	8.39e-05	CcSEcCtD
Rabeprazole—Rash—Capecitabine—prostate cancer	1.41e-05	8.38e-05	CcSEcCtD
Rabeprazole—Pruritus—Prednisone—prostate cancer	1.41e-05	8.38e-05	CcSEcCtD
Rabeprazole—Insomnia—Epirubicin—prostate cancer	1.41e-05	8.38e-05	CcSEcCtD
Rabeprazole—Dermatitis—Capecitabine—prostate cancer	1.41e-05	8.37e-05	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—prostate cancer	1.4e-05	8.36e-05	CcSEcCtD
Rabeprazole—Headache—Capecitabine—prostate cancer	1.4e-05	8.33e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Epirubicin—prostate cancer	1.4e-05	8.32e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—prostate cancer	1.39e-05	8.28e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Epirubicin—prostate cancer	1.39e-05	8.26e-05	CcSEcCtD
Rabeprazole—Somnolence—Epirubicin—prostate cancer	1.38e-05	8.23e-05	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—prostate cancer	1.37e-05	8.17e-05	CcSEcCtD
Rabeprazole—Nausea—Docetaxel—prostate cancer	1.37e-05	8.16e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Epirubicin—prostate cancer	1.37e-05	8.15e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Prednisone—prostate cancer	1.36e-05	8.1e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Epirubicin—prostate cancer	1.35e-05	8.05e-05	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—prostate cancer	1.34e-05	8.01e-05	CcSEcCtD
Rabeprazole—Pain—Epirubicin—prostate cancer	1.33e-05	7.92e-05	CcSEcCtD
Rabeprazole—Constipation—Epirubicin—prostate cancer	1.33e-05	7.92e-05	CcSEcCtD
Rabeprazole—Nausea—Capecitabine—prostate cancer	1.33e-05	7.9e-05	CcSEcCtD
Rabeprazole—Dizziness—Prednisone—prostate cancer	1.32e-05	7.83e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.31e-05	7.81e-05	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—prostate cancer	1.3e-05	7.75e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—prostate cancer	1.29e-05	7.69e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—prostate cancer	1.28e-05	7.64e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Epirubicin—prostate cancer	1.28e-05	7.63e-05	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—prostate cancer	1.28e-05	7.62e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Epirubicin—prostate cancer	1.27e-05	7.57e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—prostate cancer	1.27e-05	7.54e-05	CcSEcCtD
Rabeprazole—Vomiting—Prednisone—prostate cancer	1.26e-05	7.53e-05	CcSEcCtD
Rabeprazole—Rash—Prednisone—prostate cancer	1.25e-05	7.47e-05	CcSEcCtD
Rabeprazole—Dermatitis—Prednisone—prostate cancer	1.25e-05	7.46e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—prostate cancer	1.25e-05	7.45e-05	CcSEcCtD
Rabeprazole—Headache—Prednisone—prostate cancer	1.25e-05	7.42e-05	CcSEcCtD
Rabeprazole—Urticaria—Epirubicin—prostate cancer	1.24e-05	7.36e-05	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—prostate cancer	1.23e-05	7.33e-05	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—prostate cancer	1.23e-05	7.33e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Epirubicin—prostate cancer	1.23e-05	7.32e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Epirubicin—prostate cancer	1.23e-05	7.32e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—prostate cancer	1.19e-05	7.06e-05	CcSEcCtD
Rabeprazole—Nausea—Prednisone—prostate cancer	1.18e-05	7.03e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—prostate cancer	1.18e-05	7.01e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Epirubicin—prostate cancer	1.15e-05	6.82e-05	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—prostate cancer	1.14e-05	6.81e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—prostate cancer	1.14e-05	6.77e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—prostate cancer	1.14e-05	6.77e-05	CcSEcCtD
Rabeprazole—Asthenia—Epirubicin—prostate cancer	1.12e-05	6.64e-05	CcSEcCtD
Rabeprazole—Pruritus—Epirubicin—prostate cancer	1.1e-05	6.55e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Epirubicin—prostate cancer	1.06e-05	6.34e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—prostate cancer	1.06e-05	6.31e-05	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—prostate cancer	1.03e-05	6.15e-05	CcSEcCtD
Rabeprazole—Dizziness—Epirubicin—prostate cancer	1.03e-05	6.12e-05	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—prostate cancer	1.02e-05	6.06e-05	CcSEcCtD
Rabeprazole—Vomiting—Epirubicin—prostate cancer	9.89e-06	5.89e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—prostate cancer	9.85e-06	5.86e-05	CcSEcCtD
Rabeprazole—Rash—Epirubicin—prostate cancer	9.81e-06	5.84e-05	CcSEcCtD
Rabeprazole—Dermatitis—Epirubicin—prostate cancer	9.8e-06	5.83e-05	CcSEcCtD
Rabeprazole—Headache—Epirubicin—prostate cancer	9.74e-06	5.8e-05	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—prostate cancer	9.52e-06	5.67e-05	CcSEcCtD
Rabeprazole—Nausea—Epirubicin—prostate cancer	9.24e-06	5.5e-05	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—prostate cancer	9.15e-06	5.45e-05	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—prostate cancer	9.07e-06	5.4e-05	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—prostate cancer	9.07e-06	5.4e-05	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—prostate cancer	9.02e-06	5.37e-05	CcSEcCtD
Rabeprazole—Nausea—Doxorubicin—prostate cancer	8.55e-06	5.09e-05	CcSEcCtD
Rabeprazole—ABCG2—Metabolism—PIK3CG—prostate cancer	3.07e-06	3.79e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.06e-06	3.78e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—COMT—prostate cancer	3.06e-06	3.78e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTP1—prostate cancer	3.04e-06	3.76e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOA3—prostate cancer	3.02e-06	3.74e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2E1—prostate cancer	3.02e-06	3.73e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.99e-06	3.7e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA4—prostate cancer	2.99e-06	3.7e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ITPR1—prostate cancer	2.99e-06	3.7e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NQO1—prostate cancer	2.98e-06	3.69e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOA2—prostate cancer	2.98e-06	3.68e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.97e-06	3.67e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOA2—prostate cancer	2.95e-06	3.65e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.94e-06	3.64e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TH—prostate cancer	2.94e-06	3.64e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.92e-06	3.61e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA2—prostate cancer	2.92e-06	3.61e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP3A4—prostate cancer	2.91e-06	3.6e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—INS—prostate cancer	2.9e-06	3.59e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.89e-06	3.58e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HPGDS—prostate cancer	2.88e-06	3.57e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.88e-06	3.56e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCG5—prostate cancer	2.88e-06	3.56e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.87e-06	3.54e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.86e-06	3.54e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CREBBP—prostate cancer	2.84e-06	3.51e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.84e-06	3.51e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TYMS—prostate cancer	2.83e-06	3.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.82e-06	3.48e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA1—prostate cancer	2.82e-06	3.48e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ACHE—prostate cancer	2.8e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—prostate cancer	2.8e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—prostate cancer	2.79e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.78e-06	3.44e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTO1—prostate cancer	2.78e-06	3.44e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NAT2—prostate cancer	2.78e-06	3.44e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.78e-06	3.43e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GGT1—prostate cancer	2.77e-06	3.43e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.77e-06	3.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.75e-06	3.41e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.75e-06	3.4e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NQO1—prostate cancer	2.74e-06	3.39e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—LPL—prostate cancer	2.74e-06	3.39e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NCOA1—prostate cancer	2.73e-06	3.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NQO1—prostate cancer	2.72e-06	3.36e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TH—prostate cancer	2.7e-06	3.34e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CD—prostate cancer	2.69e-06	3.33e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.69e-06	3.33e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.69e-06	3.33e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TH—prostate cancer	2.68e-06	3.32e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.68e-06	3.31e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PRKACB—prostate cancer	2.68e-06	3.31e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.67e-06	3.3e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PLCB2—prostate cancer	2.67e-06	3.3e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LRP2—prostate cancer	2.67e-06	3.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.66e-06	3.29e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.65e-06	3.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.65e-06	3.27e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.64e-06	3.26e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.63e-06	3.25e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ERCC2—prostate cancer	2.63e-06	3.25e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—P4HB—prostate cancer	2.62e-06	3.24e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.61e-06	3.23e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.61e-06	3.22e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—RXRA—prostate cancer	2.6e-06	3.21e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GGT1—prostate cancer	2.55e-06	3.15e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.55e-06	3.15e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NOS3—prostate cancer	2.54e-06	3.15e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GGT1—prostate cancer	2.53e-06	3.12e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.52e-06	3.12e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOA2—prostate cancer	2.52e-06	3.12e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOA1—prostate cancer	2.51e-06	3.1e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—COMT—prostate cancer	2.5e-06	3.09e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTP1—prostate cancer	2.49e-06	3.08e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOA1—prostate cancer	2.49e-06	3.08e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.48e-06	3.07e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.47e-06	3.06e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MTHFR—prostate cancer	2.47e-06	3.05e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.45e-06	3.03e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ITPR1—prostate cancer	2.45e-06	3.03e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MED12—prostate cancer	2.44e-06	3.02e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARA—prostate cancer	2.42e-06	3e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GNG5—prostate cancer	2.42e-06	2.99e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.41e-06	2.98e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.41e-06	2.98e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—RXRA—prostate cancer	2.39e-06	2.95e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—RXRA—prostate cancer	2.37e-06	2.93e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.35e-06	2.91e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CB—prostate cancer	2.35e-06	2.9e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOA3—prostate cancer	2.33e-06	2.88e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—prostate cancer	2.33e-06	2.88e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NQO1—prostate cancer	2.32e-06	2.87e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TYMS—prostate cancer	2.31e-06	2.86e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.3e-06	2.85e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—COMT—prostate cancer	2.3e-06	2.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TH—prostate cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTP1—prostate cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—prostate cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—COMT—prostate cancer	2.28e-06	2.82e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAV1—prostate cancer	2.28e-06	2.82e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.28e-06	2.81e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTP1—prostate cancer	2.27e-06	2.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.27e-06	2.8e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.26e-06	2.79e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ITPR1—prostate cancer	2.25e-06	2.78e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—LPL—prostate cancer	2.24e-06	2.78e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ITPR1—prostate cancer	2.23e-06	2.76e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.23e-06	2.76e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HPGDS—prostate cancer	2.23e-06	2.75e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.21e-06	2.73e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.2e-06	2.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.18e-06	2.69e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.17e-06	2.68e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—prostate cancer	2.16e-06	2.67e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ACHE—prostate cancer	2.16e-06	2.67e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GGT1—prostate cancer	2.16e-06	2.67e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ERCC2—prostate cancer	2.15e-06	2.66e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.13e-06	2.64e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TYMS—prostate cancer	2.13e-06	2.63e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOA1—prostate cancer	2.13e-06	2.63e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TYMS—prostate cancer	2.11e-06	2.61e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—prostate cancer	2.1e-06	2.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.1e-06	2.59e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—prostate cancer	2.09e-06	2.58e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.08e-06	2.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—prostate cancer	2.08e-06	2.57e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PRKACB—prostate cancer	2.06e-06	2.55e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—LPL—prostate cancer	2.06e-06	2.55e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—LPL—prostate cancer	2.05e-06	2.53e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.04e-06	2.53e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—prostate cancer	2.03e-06	2.51e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—RXRA—prostate cancer	2.02e-06	2.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTHFR—prostate cancer	2.02e-06	2.5e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.99e-06	2.47e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARA—prostate cancer	1.98e-06	2.45e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ERCC2—prostate cancer	1.98e-06	2.45e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.98e-06	2.44e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.97e-06	2.43e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—INS—prostate cancer	1.96e-06	2.43e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ERCC2—prostate cancer	1.96e-06	2.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—COMT—prostate cancer	1.95e-06	2.41e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOA2—prostate cancer	1.95e-06	2.41e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTP1—prostate cancer	1.94e-06	2.4e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—EP300—prostate cancer	1.94e-06	2.39e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CREBBP—prostate cancer	1.92e-06	2.38e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ITPR1—prostate cancer	1.91e-06	2.36e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.88e-06	2.32e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAV1—prostate cancer	1.86e-06	2.3e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTHFR—prostate cancer	1.86e-06	2.3e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.86e-06	2.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTHFR—prostate cancer	1.84e-06	2.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CD—prostate cancer	1.82e-06	2.26e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARA—prostate cancer	1.82e-06	2.25e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.81e-06	2.24e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARA—prostate cancer	1.81e-06	2.24e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TYMS—prostate cancer	1.8e-06	2.23e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NQO1—prostate cancer	1.79e-06	2.22e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—prostate cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TH—prostate cancer	1.77e-06	2.19e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LPL—prostate cancer	1.75e-06	2.16e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NOS3—prostate cancer	1.72e-06	2.13e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.72e-06	2.13e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAV1—prostate cancer	1.71e-06	2.12e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAV1—prostate cancer	1.7e-06	2.1e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.7e-06	2.1e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.69e-06	2.09e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ERCC2—prostate cancer	1.68e-06	2.07e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GGT1—prostate cancer	1.67e-06	2.06e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOA1—prostate cancer	1.64e-06	2.03e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.62e-06	2.01e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.62e-06	2e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—INS—prostate cancer	1.61e-06	1.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.59e-06	1.97e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—prostate cancer	1.58e-06	1.95e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTHFR—prostate cancer	1.57e-06	1.95e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CREBBP—prostate cancer	1.57e-06	1.95e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.56e-06	1.93e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—RXRA—prostate cancer	1.56e-06	1.93e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARA—prostate cancer	1.54e-06	1.91e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—COMT—prostate cancer	1.5e-06	1.86e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTP1—prostate cancer	1.5e-06	1.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.49e-06	1.85e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—INS—prostate cancer	1.48e-06	1.83e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ITPR1—prostate cancer	1.47e-06	1.82e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—INS—prostate cancer	1.47e-06	1.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAV1—prostate cancer	1.45e-06	1.8e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CREBBP—prostate cancer	1.45e-06	1.79e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CREBBP—prostate cancer	1.44e-06	1.77e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—prostate cancer	1.43e-06	1.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NOS3—prostate cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TYMS—prostate cancer	1.39e-06	1.72e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.39e-06	1.72e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—prostate cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—prostate cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.36e-06	1.68e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LPL—prostate cancer	1.35e-06	1.67e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.32e-06	1.64e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—EP300—prostate cancer	1.31e-06	1.62e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.3e-06	1.61e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.3e-06	1.61e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NOS3—prostate cancer	1.3e-06	1.6e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ERCC2—prostate cancer	1.29e-06	1.6e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—prostate cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NOS3—prostate cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—INS—prostate cancer	1.25e-06	1.55e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CREBBP—prostate cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTHFR—prostate cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARA—prostate cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—prostate cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—prostate cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—prostate cancer	1.17e-06	1.45e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—prostate cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAV1—prostate cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NOS3—prostate cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—EP300—prostate cancer	1.07e-06	1.33e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—prostate cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—prostate cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.01e-06	1.25e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—prostate cancer	1e-06	1.24e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—EP300—prostate cancer	9.86e-07	1.22e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—EP300—prostate cancer	9.78e-07	1.21e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—prostate cancer	9.69e-07	1.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—INS—prostate cancer	9.67e-07	1.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CREBBP—prostate cancer	9.47e-07	1.17e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.98e-07	1.11e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—prostate cancer	8.76e-07	1.08e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NOS3—prostate cancer	8.48e-07	1.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—EP300—prostate cancer	8.35e-07	1.03e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.93e-07	9.81e-06	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—prostate cancer	7.92e-07	9.79e-06	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.82e-07	9.67e-06	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—prostate cancer	7.75e-07	9.59e-06	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.3e-07	9.02e-06	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.23e-07	8.94e-06	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—prostate cancer	6.76e-07	8.36e-06	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—prostate cancer	6.48e-07	8.01e-06	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—EP300—prostate cancer	6.45e-07	7.97e-06	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.18e-07	7.64e-06	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—prostate cancer	5.96e-07	7.37e-06	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—prostate cancer	5.91e-07	7.3e-06	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—prostate cancer	5.05e-07	6.24e-06	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.77e-07	5.9e-06	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—prostate cancer	3.9e-07	4.82e-06	CbGpPWpGaD
